About this trial
The purpose of this research study is to provide preliminary evidence of whether telerehabilitation targeting arm movement, when added to usual care, improves arm function and reduces global disability after stroke, compared to usual care alone in Brazil. Evaluate the safety and feasibility of telerehabilitation in the Brazilian context. Explore the clinical, neuroimaging, neurophysiological, and economic factors that influence telerehabilitation efficacy in functional recovery following stroke.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 18-80 years at the time of randomization.
The index stroke was radiologically verified, due to ischemia, and had time of onset 120±30 days prior to randomization.
The stroke caused upper extremity deficits as defined by Action Research.
Arm Test score 18-44 (out of 57) at Baseline Visit.
Disqualifiers
A major, active, coexistent neurological, psychiatric, or medical disease that reduces the likelihood that a subject will be able to comply with all study procedures.
Unable or unwilling to perform study procedures/therapy, or expectation of noncompliance with study procedures/therapy, or expectation that subject cannot participate in all study visits.
A diagnosis (apart from the index stroke) that substantially affects paretic arm function.
Severe depression, defined as Geriatric Depression Scale Score >10/15 at Baseline Visit.
Trial design
Parallel
Treatments tested in this trial
Telerehabilitation
DeviceParticipants will receive 36 telerehabilitation sessions targeting arm motor function in addition to their usual care. TR consists of 70 minutes/day of activities targeting arm function, 6 days/week for 6 weeks. Half of these sessions are supervised by a licensed therapist, and the other half are done independently.
Usual Care
Other interventionUsual care rehabilitation refers to the recommendations made by their care team.
Treatment groups
Trial outcomes
Primary outcomes
Change in Action Research Arm Test (ARAT) Score from baseline to the early post-intervention.
Change in Action Research Arm Test (ARAT) Score from baseline to the early post-intervention. The ARAT scale measures arm function using a scale that runs from 0 to 57 points, with higher numbers reflecting better arm function.
Study feasibility in the Brazilian context - recruitment.
Proportion of eligible participants who agree to take part in the study.
Study feasibility in the Brazilian context - adherence.
Proportion of participants who complete TR therapy with sessions of 40 minutes or longer.
Study feasibility in the Brazilian context - retention.
Proportion of dropouts during the study participation period.
Secondary outcomes
Change in Action Research Arm Test (ARAT) Score from baseline to 1 month post-intervention.
Change in Action Research Arm Test (ARAT) Score from baseline to 1 month post-intervention. The ARAT scale measures arm function using a scale that runs from 0 to 57 points, with higher numbers reflecting better arm function.
Treatment-related adverse events reported by the participants.
Number and severity of adverse events related to the telerehabilitation intervention reported by the participants.
Other outcomes
White matter integrity assessed using diffusion tensor imaging (DTI) magnetic resonance imaging (MRI).
Cortical spinal tract integrity - lesion load (predictive factor).
Interhemispheric connectivity of motor cortices assessed using resting-state functional magnetic resonance imaging (rs-fMRI).
rs-fMRI interhemispheric functional connectivity in the primary motor cortex (predictive factor).
Motor cortex mapping and motor representation assessed using neuronavigated transcranial magnetic stimulation (nTMS).
nTMS motor mapping (predictive factor).
Interhemispheric connectivity of motor cortices assessed using resting-state functional electroencephalography (rsEEG).
rsEEG interhemispheric functional connectivity in the primary motor cortex (predictive factor).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Sao Paulo
Lead sponsor
Ribeirão Preto Medical School, University of São Paulo
Collaborator
Clinical Hospital, Ribeirão Preto Medical School, University of São Paulo
Collaborator
University of California, Los Angeles
Collaborator
Thomas Jefferson University
Collaborator
Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School
Collaborator